Showing results (231-240 of 624) with videos related to

Sort By:
Pageof 63
Leukemia Research|January 1, 1982
B-cell acute lymphoid leukemia (ALL) with lymphoblasts expressing surface immunoglobulins only at relapseG De Rossi, G Alimena, C Guglielmi, et al.
Journal of Clinical Medicine|April 5, 2020
Make Sure You Have a Safety Net: Updates in the Prevention and Management of Infectious Complications in Stem Cell Transplant RecipientsCarlos A Q Santos, Yoona Rhee, Michael T Czapka, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 2014
HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer modelsLuke Whitesell, Sandro Santagata, Marc L Mendillo, et al.
Transplantation|September 30, 1998
Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantationM Muscaritoli, L Conversano, G F Torelli, et al.
Transplantation|August 1, 1981
Biochemical characterization of Syrian hamster cell surface alloantigens. III. Hamster alloantisera immunoprecipitate class II-like, but not class I-like, moleculesJ W Streilein, J T Phillips, J Stein-Streilein, et al.
Cancer|August 1, 1990
Mitoxantrone for refractory and relapsed acute leukemiaW R Bezwoda, C Bernasconi, R M Hutchinson, et al.
Leukemia|May 1, 1996
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemiaS Amadori, A Picardi, P Fazi, et al.
British Journal of Haematology|November 1, 1996
Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferonM C Petti, R Latagliata, G Avvisati, et al.
Leukemia Research|January 1, 1984
PHA-ICC, ADCC and NK in patients with ANLL in CR: human fibroblastic interferon fails to increase NK-active cell frequencyL Fontana, G De Rossi, G De Sanctis, et al.
Haematologica|December 29, 1998
Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapyG Martinelli, E Ottaviani, N Testoni, et al.
Pageof 63